InvestorsHub Logo
Followers 21
Posts 2233
Boards Moderated 0
Alias Born 02/22/2005

Re: steve butabi post# 18353

Monday, 11/05/2007 8:25:34 AM

Monday, November 05, 2007 8:25:34 AM

Post# of 346248
steve -

I'm not sure what the first dose amount is. Without knowing that, it's hard to make any 'educated guesses'. I'm assuming it's at least 0.3, but have note heard yet.
I do expect impressive results against HIV based on bavi's multiple MOA's-

(this is from Phil Thorpe's UTSW page) -

* We have found that PS becomes exposed on the external surface of virally infected cells,

* Bavituximab achieves its protective effects by directing host cells to kill the virally-infected cells

* and by causing opsonization and clearance of virions from the bloodstream.

* In addition, the antibody appears to negate PS-mediated immunosuppressive signals

(which is the fascinating MOA that I post all the corroborative papers about)...



------------



j
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News